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Introduction

Anti-Synthetase Syndrome is a rare disease seen most commonly in patients
with auto-immune inflammatory myopathies such as dermatomyositis.
Typical characteristics of this exceedingly rare syndrome are arthropathy,
interstitial lung disease (ILD), the presence of antibodies against amino-acyl
tRNA synthetases, and rarely the typical myositis associated with these
antibodies. We describe the unfortunate case of a patient with rapidly
progressive ILD and acute hypoxic respiratory failure necessitating bilateral
lung transplantation.

Imaging

Case presentation

A 47-year-old female with past medical history significant for hypothyroidism
and hyperlipidemia presented to the office with one month of progressively
worsening dyspnea and productive cough; her initial chest radiography
showed bilateral, multi-focal infiltrates. A bronchoalveolar lavage and
transbronchial and endobronchial biopsies were performed via bronchoscopy
without significant findings. Extensive infectious work-up was negative. Only
a few days later, she was admitted to the hospital with severe hypoxemia.
Computed tomography of the chest without contrast demonstrated worsening
bilateral airspace disease and rapidly progressing traction bronchiectasis
(Images 1 and 2). Video-assisted thorascopic surgery (VATS) was performed
and wedge biopsy demonstrated alveolar tissue containing fibrin with
surrounding cellular fibrosis. Extensive immunological work-up returned
positive for the anti-histidyl-tRNA synthetase antibody, Anti-Jo-1, highly
suggestive of a diagnosis of Anti-Synthetase Syndrome. She was initiated
on pulse dose steroids and transferred to a transplant center where she
received bilateral lung transplantation.
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Image 1. Diffuse airspace disease with traction
bronchiectasis.

Discussion

•	Anti-Synthetase Syndrome is a rare auto-immune disease that has
significant systemic manifestations.
•	Commonly accepted diagnostic criteria for Anti-Synthetase Syndrome
include the presence of an anti-aminoacyl tRNA synthetase antibody and
evidence of ILD, Raynaud’s phenomenon, arthritis, or mechanic’s hands.
•	While this disease falls within the clinical realm of the inflammatory
myopathies, clinicians must be aware that this syndrome can and often
does present primarily with rapidly progressing ILD, being the primary
mediator of morbidity and mortality in these patients.
•	Clinical suspicion for autoimmune disease should be high, particularly in
patients with rapidly deteriorating respiratory function without evidence of
active infection.

Conclusion

•	This case demonstrates the importance of expeditious and accurate
identification of autoimmune etiologies in patients presenting with
respiratory decline.
•	It is critical to eliminate treatable infectious etiologies to allow for initiation
of immunosuppressive therapy.
•	A low threshold for evaluation for transplant should also occur with rapidly
progressing ILD associated with autoimmune features or serologies.
Image 2. Coronal view of patient’s extensive
lung disease.
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